Zhanjun Hou
Zhanjun Hou
Position Title
Professor - Research
Basic Science
Office Location
Karmanos Cancer Institute
Elliman Building, RM - 3120
421 E Canfield
Detroit, MI 48201
Mailing Address
Office Phone
(313) 578-4372
Office Fax
(313) 578-4287Education Training
Education
(1998) PhD Plant Pathology, China Agricultural University, China
(1995) MS Plant Pathology, China Agricultural University, China
(1992) BS, Agricultural and Husbandry, University of Inner Mongolia, China
Postgraduate Training
(2001-2004) Post-doctoral Research Fellow/Research Associate, Department of Biochemistry & Molecular Biology, Wayne State University School of Medicine, Detroit, MI
Professional Experience
Faculty Appointments
(2024-Present) Professor - Research, Department of Oncology Wayne State University School of Medicine, Detroit, MI
(2018-2024) Associate Professor - Research, Department of Oncology Wayne State University School of Medicine, Detroit, MI
(2013-2018) Assistant Professor, - Research, Department of Oncology, Wayne State University School of Medicine, Detroit, MI
Other Hospital or Professional Appointments
(2007-2012) Research Scientist, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI
(2004-2007) Research Associate, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI
(1998-2000) Research Associate, Department of Plant Pathology, China Agricultural University
Major Professional Societies
American Association for Cancer Research
American Society of Biochemistry and Molecular Biology
Honors and Awards
(2015) Wayne State University School of Medicine Research Incentive Award
(2014) Wayne State University School of Medicine Research Incentive Award
(2013) Wayne State University School of Medicine Research Incentive Award
(2010) The Karmanos Cancer Center Director;s Research highlights
(2009) The Karmanos Cancer Center Director's Research Award
Research Interests
My research interest has been on structural and functional studies on physiologically and pharmacologically important folate membrane transporters, including human reduced folate carrier (hRFC) and the human proton-coupled folate transporter (hPCFT). Using a wide range of state-of-art biochemical technologies including scanning cysteine mutagenesis and cysteine-scanning accessibility methods (SCAM), the important amino acid residues involved in hRFC function and substrate binding were dissected. As an extension of this work, I also identified and functionally characterized the oligomeric structure and functional consequences of oligomerization for both hRFC and hPCFT. This was a landmark discovery in the folate transport field with particular ramifications to therapeutic uses of cytotoxic folate analogs for cancer. During my research work on membrane transport proteins, I have established a number of techniques for studying membrane protein structure-function, including FRET and blue-native polyacrylamide gel electrophoresis. In addition, I am also interested in molecular homology modeling these facilitative folate transporters. More recently, I started to turn a portion of my research interest toward discovery and development of new folate-based therapeutics for cancer and other diseases that selectively use high affinity folate receptors and/or hPCFT without substrate activity for hRFC. Drawing from my experience in therapeutic applications of folate analog membrane transport and drug development, my current research focus is on developing novel therapeutic approaches for non-small cell lung cancer (NSCLC) by using state-of-the-art metabolomics profiling. I am also extending these methods to discovery of novel biomarkers for early diagnosis of NSCLC.
Publications
3. Wilson, M.R., Hou, Z., Matherly, L.H., 2014. Substituted cysteine accessibility reveals a novel transmembrane 2-3 reentrant loop and functional role for transmembrane domain 2 in the human proton-coupled folate transporter. J. Biol. Chem. 289(36): 25287-95
4. Hou, Z., Orr, S., Matherly, L.H., 2014. Posttranscriptional regulation of the human reduced folate carrier as a novel adaptive mechanism in response to folate excess or deficiency. BioScience Report. 34(4): 457-468
Zhanjun Hou, PhD - PubMed